Skip to content

Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast Surgery

Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02905149
Enrollment
60
Registered
2016-09-19
Start date
2016-08-02
Completion date
2017-07-08
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction, Surgery

Keywords

Oncological, Surgery, Breast, Reconstruction

Brief summary

The purpose of this project is to evaluate the analgesic efficacy of a regional anesthesia technique ( interfascial block at the serratus muscle) performed in patient undergoing breast surgery and the effect of this technique on postoperative analgesia.

Detailed description

Regional analgesia techniques have shown to have benefits over conventional analgesia. The lower opioids analgesics requirements decrease side effects associated with the use of this type of medication. It is also increasingly established scientific evidence that reducing opioids administration may play a role in prognosis of cancer patients given the immunosuppressive effect of these drugs. In patients undergoing oncologic/reconstructive breast surgery paravertebral block has been traditionally performed, however the paravertebral space lacks a clear anatomical barrier from the spinal cord so the drugs administered can diffuse to the intervertebral foramen causing deeper levels of blocks (epidural or spinal blocks) and injections at the paravertebral level are associated with serious complications both neurological and respiratory (meningitis, spinal hematomas abscesses, pneumothorax, respiratory failure. This has led to the development of less invasive technique with an improved safety profile. The serratus plane block falls within the framework of these newly developed techniques and the present study aims to assess its role in the management of the patient undergoing cancer / reconstructive surgery. Considering a decrease in postoperative morphine consumption of 40% and the average consumption of opioid after breast surgery under general anesthesia is 15 milligrams ( standard deviation 8 mg ) investigators calculated that with an alpha error 5% power 80 % 56 patients (28 per group) were required to achieve a significant result. In anticipation of possible loss of sample, 60 patients were recruited . Analysis will be performed by intention to treat. Quantitative variables (opioid consumption, pain estimated by VAS scale) will be analyzed using mixed linear model adding a random variable for interindividual variability for pain threshold. If the data do not meet the criteria of normality the Mann-Whitney U test will be used. If the groups differ in preoperative variables. Investigators will make a multivariable analysis adjusting for these variables. The need for rescue analgesia over time is analyzed by Kaplan-Meier curve where the terminal state is the administration of the first dose of opioid postoperatively. The difference side effects (nausea, pruritus, apnea, urinary retention, ileus ) and complications IPO questionnaire and analyzed by chi-square test and Fisher exact test. Scheffe correction will be applied for multiple comparison. Missing data are excluded from analysis. The study has planned data monitoring and auditing by the IIS la Fe according to AEMPS guidelines. Registries will be obtained from electronic medical records available for double check procedures.

Interventions

PROCEDURESerrato

Serratus plane block.

PROCEDUREControl

Standard anesthesia

Sponsors

Instituto de Investigacion Sanitaria La Fe
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Two group parallel arm. With study group receiving regional anesthestic block with levobupivacaine and control group receiving standard care with intravenous analgesia only

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years, undergoing oncological surgery and/or breast reconstruction surgery whose pathology and surgical intervention supose at least a 24 hours hospital admission

Exclusion criteria

* ASA Physical Status Classification System- IV.- Morbid obesity (Body mass index \>40). -Impossibility of anatomical structures ultrasound identification in a satisfactory way (there can be no distinction in the interfascial plane between serratus and pectoral muscle). -Opioids treatment before surgery. Sepsis and/or infection at the puncture site. * Haemostasis disorders. - Allergy to any of the drugs used in the study.

Design outcomes

Primary

MeasureTime frameDescription
Total Opioid UsageFirst 24 hours after surgeryTotal opioid usage in the first 24 hours (intra and postoperative) (in morphine milligrmas, fentanyl/morphine conversion = 10 mcgs/1mg). Opioid used will be fentanyl and morphine. Fentanyl will be converted in morphine milligrams equivlents to caluclate the total first 24H dose.

Secondary

MeasureTime frameDescription
Pain at Rest and CoughingFirst 24 hours after surgeryPain at rest and coughing at 24h postoperative (Visual analogue scale 0-10 with 0 meaning no pain and 10 meaning the worst imaginable pain). High score mean worse outcomes
Time to First Opioid Administration on the WardFirst 24 hours after surgeryTime to first opioid administration on the ward
Presence of Opioid Related ComplicationsFirst 24 hours after surgerypresence of nausea/vomit or apnea or urinary retention or ileus is assessed. It is a dicothomic composite (yes or no).

Countries

Spain

Participant flow

Participants by arm

ArmCount
Serrato
Standard anesthesia+serratus plane block. Serrato: Serratus plane block.
30
Control
Standard anesthesia Control: Standard anesthesia
30
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up20

Baseline characteristics

CharacteristicControlTotalSerrato
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
12 Participants25 Participants13 Participants
Age, Categorical
Between 18 and 65 years
18 Participants35 Participants17 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Spain
30 participants60 participants30 participants
Sex: Female, Male
Female
30 Participants60 Participants30 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 30
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Total Opioid Usage

Total opioid usage in the first 24 hours (intra and postoperative) (in morphine milligrmas, fentanyl/morphine conversion = 10 mcgs/1mg). Opioid used will be fentanyl and morphine. Fentanyl will be converted in morphine milligrams equivlents to caluclate the total first 24H dose.

Time frame: First 24 hours after surgery

Population: 2 participants were lost to follow up because of malfunctioning of the electronic device administering the potoperative opioid

ArmMeasureValue (MEDIAN)
SerratoTotal Opioid Usage18.5 milligrams
ControlTotal Opioid Usage30 milligrams
p-value: <0.0595% CI: [4, 14.5]Wilcoxon (Mann-Whitney)
Secondary

Pain at Rest and Coughing

Pain at rest and coughing at 24h postoperative (Visual analogue scale 0-10 with 0 meaning no pain and 10 meaning the worst imaginable pain). High score mean worse outcomes

Time frame: First 24 hours after surgery

ArmMeasureGroupValue (MEDIAN)
SerratoPain at Rest and CoughingWorst pain in 24h4 units on a scale
SerratoPain at Rest and CoughingLeast pain in 24h0 units on a scale
SerratoPain at Rest and CoughingPain interf. with activities in bed1 units on a scale
SerratoPain at Rest and CoughingPain interf. with breathing or coughing0 units on a scale
ControlPain at Rest and CoughingPain interf. with breathing or coughing0 units on a scale
ControlPain at Rest and CoughingWorst pain in 24h6 units on a scale
ControlPain at Rest and CoughingPain interf. with activities in bed1 units on a scale
ControlPain at Rest and CoughingLeast pain in 24h0 units on a scale
Secondary

Presence of Opioid Related Complications

presence of nausea/vomit or apnea or urinary retention or ileus is assessed. It is a dicothomic composite (yes or no).

Time frame: First 24 hours after surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SerratoPresence of Opioid Related Complications0 Participants
ControlPresence of Opioid Related Complications0 Participants
Secondary

Time to First Opioid Administration on the Ward

Time to first opioid administration on the ward

Time frame: First 24 hours after surgery

ArmMeasureValue (MEAN)
SerratoTime to First Opioid Administration on the Ward7.95 hours
ControlTime to First Opioid Administration on the Ward2.9 hours

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026